Sarah A Carratt

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Venues

Leukemia

Nature communications

Molecular cancer therapeutics

Blood

Oregon Health and Science University

University of California Davis (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oregon Health and Science University

United States

Postdoctoral Scholar :: Knight Cancer Institute, Hematology and Medical Oncology

Education History

University of California Davis

United States

PHD :: Pharmacology and Toxicology

Loyola Marymount University

United States

BSC :: Biology

Publications

Haley D Neff-LaFord, Sarah A Carratt, Christopher Carosino, Nancy Everds, Kristen A Cardinal, Steven Duniho, Melissa M Schutten, Christopher Frantz, Christina Zuch de Zafra, Eric B Harstad
The vedotin antibody-drug conjugate payload drives platform-based nonclinical safety and pharmacokinetic profiles. Molecular cancer therapeutics (2024)
Sarah A Carratt, Garth L Kong, Cody Coblentz, Zachary Schonrock, Lauren Maloney, Benjamin R Weeder, William M Yashar, Rowan Callahan, Hunter Z Blaylock, Colin Coleman, Dan Coleman, Theodore P Braun, Julia E Maxson
RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development. Leukemia (2023)
Sarah A Carratt, Garth L Kong, Brittany M Curtiss, Zachary Schonrock, Lauren Maloney, Breanna N Maniaci, Hunter Z Blaylock, Adrian Baris, Brian J Druker, Theodore P Braun, Julia E Maxson
Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms. Blood 140 (6) (2022)
Theodore P Braun, Mariam Okhovat, Cody Coblentz, Sarah A Carratt, Amy Foley, Zachary Schonrock, Brittany M Curtiss, Kimberly Nevonen, Brett A Davis, Brianna Garcia, Dorian LaTocha, Benjamin R Weeder, Michal R Grzadkowski, Joey C Estabrook, Hannah G Manning, Kevin Watanabe-Smith, Sophia Jeng, Jenny L Smith, Amanda R Leonti, Rhonda E Ries, Shannon K McWeeney, Cristina Di Genua, Roy Drissen, Claus Nerlov, Soheil Meshinchi, Lucia Carbone, Brian J Druker, Julia E Maxson
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia. Nature communications 13 (1) (2022)
Sarah A Carratt, Theodore P Braun, Cody Coblentz, Zachary Schonrock, Rowan Callahan, Brittany M Curtiss, Lauren Maloney, Amy C Foley, Julia E Maxson
Correction to: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia. Leukemia (2022)
Sarah A Carratt, Theodore P Braun, Cody Coblentz, Zachary Schonrock, Rowan Callahan, Brittany M Curtiss, Lauren Maloney, Amy C Foley, Julia E Maxson
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia. Leukemia 35 (12) (2021)
Theodore P Braun, Mariam Okhovat, Cody Coblentz, Sarah A Carratt, Amy Foley, Zachary Schonrock, Brittany M Smith, Kimberly Nevonen, Brett A Davis, Brianna Garcia, Dorian LaTocha, Benjamin R Weeder, Michal R Grzadkowski, Joey C Estabrook, Hannah G Manning, Kevin Watanabe-Smith, Sophia Jeng, Jenny L Smith, Amanda R Leonti, Rhonda E Ries, Shannon K McWeeney, Cristina Di Genua, Roy Drissen, Claus Nerlov, Soheil Meshinchi, Lucia Carbone, Brian J Druker, Julia E Maxson
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia. Nature communications 10 (1) (2019)

Sarah A Carratt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sarah A Carratt